Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 10134933Search this ID in NIH RePORTER
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.
NIH Funding · FY2024
Linked Award Amount
$3.3M
Full award amounts, FY2024
Award Records
4
Records listing this PI
Award-Linked Rank
#2,238
By linked amount among FY2024 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2024 award records by amount
NIH award records listing Elke Lipka as a PI. Multi-PI records show the full award amount for context.
- 4R44AI179506-02R44Novel, Self-Applied MicroArray Patch (MAP) of Zanamivir for Treatment of the Flu$999.7Kaward amount
- 5R44AI129122-08R44Microneedle Delivery of Zanamivir for the Treatment of Influenza Infections$998.7Kaward amount
- 5R44AI134190-05R44Development of MRS-2541, a methionyl-tRNA synthetase inhibitor, for Gram positive bacterial infections.$997.7Kaward amount
- 1U44AI184201-01U44Phase 1 Clinical Trial to Assess the Pharmacokinetics, Safety and Tolerance of a Zanamivir Transdermal System in Healthy Subjects$292.7Kaward amount
Award organization
Organizations that administered FY2024 awards listing Elke Lipka as a PI.
FY2024 award administered by Tsrl, Inc. (MI).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardTsrl, Inc.
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2024$2M Cumulative Funding
- 2024Entered Top 50% NationallyRanked #2238
- 2024Entered Top 25% NationallyRanked #2238
- 2025$5M Cumulative Funding